Raras
Buscar doenças, sintomas, genes...
Síndrome nefrótica idiopática
ORPHA:357502PCDT · SUSDOENÇA RARA

Síndrome nefrótica sem causa conhecida.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Síndrome nefrótica sem causa conhecida.

Pesquisas ativas
12 ensaios
54 total registrados no ClinicalTrials.gov
Publicações científicas
1.663 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Cobertura mínimaScore: 30%
PCDT disponível
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
18 sintomas
😀
Face
11 sintomas
🧠
Neurológico
5 sintomas
🩸
Sangue
4 sintomas
🦴
Ossos e articulações
3 sintomas
🫁
Pulmão
3 sintomas

+ 24 sintomas em outras categorias

Características mais comuns

Anormalidade do sistema nervoso
Atraso global do desenvolvimento
Clinodactilia
Fenda labial
Palato ogival
Filtro liso
72sintomas
Sem dados (72)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 72 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do sistema nervosoAbnormality of the nervous system
Atraso global do desenvolvimentoGlobal developmental delay
ClinodactiliaClinodactyly
Fenda labialCleft lip
Palato ogivalHigh palate

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.663PubMed
Últimos 10 anos200publicações
Pico202586 papers
Linha do tempo
2026Hoje · 2026🧪 2002Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

35 genes identificados com associação a esta condição.

NUP107Nuclear pore complex protein Nup107Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance (PubMed:12552102, PubMed:15229283, PubMed:30179222). Required for the assembly of peripheral proteins into the NPC (PubMed:12552102, PubMed:15229283). May anchor NUP62 to the NPC (PubMed:15229283). Involved in nephrogenesis (PubMed:30179222)

LOCALIZAÇÃO

Nucleus membraneNucleus, nuclear pore complexChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Nephrotic syndrome 11

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. NPHS11 is an autosomal recessive, steroid-resistant and progressive form with onset in the first decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
28.5 TPM
Testículo
21.7 TPM
Fibroblastos
18.6 TPM
Cervix Endocervix
17.4 TPM
Nervo tibial
17.3 TPM
OUTRAS DOENÇAS (6)
nephrotic syndrome, type 11ovarian dysgenesis 6Galloway-Mowat syndrome 7Galloway-Mowat syndrome
HGNC:29914UniProt:P57740
APOL1Apolipoprotein L1Candidate gene tested inTolerante
FUNÇÃO

May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver. A component of trypanosome lytic factor of human serum; plays a crucial role in killing Trypanosoma brucei by forming pores in parasite lysosomal membranes and sensitizing T.brucei to oxidation-stimulated osmotic lysis (PubMed:12621437, PubMed:16020735, PubMed:19997494, PubMed:26645690, PubMed:7723792)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 4

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

OUTRAS DOENÇAS (2)
familial idiopathic steroid-resistant nephrotic syndromefocal segmental glomerulosclerosis 4, susceptibility to
HGNC:618UniProt:O14791
MAGI2Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2Candidate gene tested inAltamente restrito
FUNÇÃO

Seems to act as a scaffold molecule at synaptic junctions by assembling neurotransmitter receptors and cell adhesion proteins (By similarity). Plays a role in nerve growth factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth (By similarity). May play a role in regulating activin-mediated signaling in neuronal cells (By similarity). Enhances the ability of PTEN to suppress AKT1 activation (PubMed:10760291). Plays a role in receptor-mediated clathrin-dependent endocy

LOCALIZAÇÃO

CytoplasmLate endosomeSynapse, synaptosomeCell membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, ciliumCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolePhotoreceptor inner segmentCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Nephrin family interactions
MECANISMO DE DOENÇA

Nephrotic syndrome 15

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. NPHS15 is an autosomal recessive form with onset in the first months of life. Disease severity is variable. Some patients show rapid progression to end-stage renal failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
5.9 TPM
Brain Frontal Cortex BA9
5.2 TPM
Nervo tibial
4.7 TPM
Brain Caudate basal ganglia
4.5 TPM
Córtex cerebral
4.3 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome 15familial idiopathic steroid-resistant nephrotic syndrome
HGNC:18957UniProt:Q86UL8
NUP85Nuclear pore complex protein Nup85Candidate gene tested inAltamente restrito
FUNÇÃO

Essential component of the nuclear pore complex (NPC) that seems to be required for NPC assembly and maintenance (PubMed:12718872). As part of the NPC Nup107-160 subcomplex plays a role in RNA export and in tethering NUP96/Nup98 and NUP153 to the nucleus (PubMed:12718872). The Nup107-160 complex seems to be required for spindle assembly during mitosis (PubMed:16807356). NUP85 is required for membrane clustering of CCL2-activated CCR2 (PubMed:15995708). Seems to be involved in CCR2-mediated chemo

LOCALIZAÇÃO

Nucleus, nuclear pore complexChromosome, centromere, kinetochoreCytoplasm, cytoskeleton, spindleCytoplasmNucleus membrane

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Nephrotic syndrome 17

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS17 is an autosomal recessive, steroid-resistant progressive form with onset in the first decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
55.5 TPM
Cerebelo
51.1 TPM
Nervo tibial
37.5 TPM
Cervix Endocervix
35.1 TPM
Cervix Ectocervix
35.0 TPM
OUTRAS DOENÇAS (3)
nephrotic syndrome, type 17Seckel syndromefamilial idiopathic steroid-resistant nephrotic syndrome
HGNC:8734UniProt:Q9BW27
NUP37Nucleoporin Nup37Candidate gene tested inTolerante
FUNÇÃO

Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation

LOCALIZAÇÃO

Chromosome, centromere, kinetochoreNucleus, nuclear pore complex

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Microcephaly 24, primary, autosomal recessive

A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH24 patients additionally manifest mildly impaired intellectual development, cerebellar vermis hypoplasia, and fifth finger clinodactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.2 TPM
Fibroblastos
23.2 TPM
Testículo
12.7 TPM
Esôfago - Mucosa
11.0 TPM
Fallopian Tube
9.8 TPM
OUTRAS DOENÇAS (3)
microcephaly 24, primary, autosomal recessivefamilial idiopathic steroid-resistant nephrotic syndromeautosomal recessive primary microcephaly
HGNC:29929UniProt:Q8NFH4
KANK2KN motif and ankyrin repeat domain-containing protein 2Candidate gene tested inTolerante
FUNÇÃO

Involved in transcription regulation by sequestering in the cytoplasm nuclear receptor coactivators such as NCOA1, NCOA2 and NCOA3 (PubMed:17476305). Involved in regulation of caspase-independent apoptosis by sequestering the proapoptotic factor AIFM1 in mitochondria (PubMed:22371500). Pro-apoptotic stimuli can induce its proteasomal degradation allowing the translocation of AIFM1 to the nucleus to induce apoptosis (PubMed:22371500). Involved in the negative control of vitamin D receptor signali

LOCALIZAÇÃO

CytoplasmMitochondrion

MECANISMO DE DOENÇA

Palmoplantar keratoderma and woolly hair

A disorder characterized by abnormal thickening of the skin on the palms and soles, in association with woolly scalp hair. Affected individuals manifest a variable degree of striate palmoplantar keratoderma, generally more severe on the soles. Leukonychia is more pronounced on the fingernails than toenails. Scalp hair, body hair, eyebrows, and eyelashes are sparse. The fifth toes show variable degrees of pseudoainhum, ranging from external rotation to a deep sulcus at the digitoplantar fold, accompanied by a bulbous appearance of the distal toe.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
425.3 TPM
Cólon sigmoide
398.8 TPM
Artéria tibial
390.4 TPM
Esôfago - Muscular
388.1 TPM
Esôfago - Junção
370.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
nephrotic syndrome 16wooly hair-palmoplantar keratoderma syndromefamilial idiopathic steroid-resistant nephrotic syndrome
HGNC:29300UniProt:Q63ZY3
ANKFY1Ankyrin repeat and FYVE domain-containing protein 1Candidate gene tested inAltamente restrito
FUNÇÃO

Proposed effector of Rab5 (PubMed:15328530). Binds to phosphatidylinositol 3-phosphate (PI[3]P) (PubMed:15328530). Involved in homotypic early endosome fusion and to a lesser extent in heterotypic fusion of clathrin-coated vesicles with early endosomes (PubMed:15328530). Involved in macropinocytosis; the function is dependent on Rab5-GTP (PubMed:15328530). Required for correct endosomal localization (PubMed:15328530). Involved in the internalization and trafficking of activated tyrosine kinase r

LOCALIZAÇÃO

CytoplasmEndosome membraneEarly endosome

VIAS BIOLÓGICAS (1)
RHOD GTPase cycle
VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
familial idiopathic steroid-resistant nephrotic syndrome
HGNC:20763UniProt:Q9P2R3
INF2Inverted formin-2Candidate gene tested inAltamente restrito
FUNÇÃO

Severs actin filaments and accelerates their polymerization and depolymerization

LOCALIZAÇÃO

Cytoplasm, perinuclear region

MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 5

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
204.3 TPM
Artéria tibial
83.2 TPM
Artéria coronária
78.6 TPM
Aorta
69.0 TPM
Brain Spinal cord cervical c-1
68.8 TPM
OUTRAS DOENÇAS (3)
Charcot-Marie-Tooth disease dominant intermediate Efocal segmental glomerulosclerosis 5familial idiopathic steroid-resistant nephrotic syndrome
HGNC:23791UniProt:Q27J81
TRPC6Short transient receptor potential channel 6Candidate gene tested inTolerante
FUNÇÃO

Forms a receptor-activated non-selective calcium permeant cation channel (PubMed:19936226, PubMed:23291369, PubMed:26892346, PubMed:9930701). Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Activated by diacylglycerol (DAG) in a membrane-delimited fashion, independently of protein kinase C (PubMed:26892346). Does not seem to be activated by intracellular calcium store depletion

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (4)
Effects of PIP2 hydrolysisElevation of cytosolic Ca2+ levelsRole of second messengers in netrin-1 signalingTRP channels
MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 2

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
23.2 TPM
Esôfago - Muscular
19.0 TPM
Tireoide
12.0 TPM
Esôfago - Junção
9.5 TPM
Tecido adiposo
7.9 TPM
OUTRAS DOENÇAS (2)
focal segmental glomerulosclerosis 2familial idiopathic steroid-resistant nephrotic syndrome
HGNC:12338UniProt:Q9Y210
COL4A3Collagen alpha-3(IV) chainCandidate gene tested inTolerante
FUNÇÃO

Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen Tumstatin, a cleavage fragment corresponding to the collagen alpha 3(IV) NC1 domain, possesses both anti-angiogenic and anti-tumor cell activity; these two anti-tumor properties may be regulated via RGD-independent ITGB3-mediated mechanisms

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (1)
Collagen degradation
OUTRAS DOENÇAS (6)
hematuria, benign familial, 2Alport syndrome 3b, autosomal recessiveautosomal dominant Alport syndromeautosomal recessive Alport syndrome
HGNC:2204UniProt:Q01955
MYO1EUnconventional myosin-IeCandidate gene tested inRestrito
FUNÇÃO

Actin-based motor molecule with ATPase activity (PubMed:11940582, PubMed:36316095). Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Involved in clathrin-mediated endocytosis and intracellular movement of clathrin-coated vesicles (PubMed:36316095). Required for normal morphology of the glomerular basement

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCytoplasmic vesicleCytoplasmic vesicle, clathrin-coated vesicleCell junction

MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 6

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. FSGS6 is a childhood-onset disorder resulting in nephrotic syndrome, which includes massive proteinuria, hypoalbuminemia, hyperlipidemia, and edema.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
52.2 TPM
Artéria tibial
41.9 TPM
Fibroblastos
40.6 TPM
Aorta
31.5 TPM
Nervo tibial
30.7 TPM
OUTRAS DOENÇAS (2)
focal segmental glomerulosclerosis 6familial idiopathic steroid-resistant nephrotic syndrome
HGNC:7599UniProt:Q12965
WT1Wilms tumor proteinCandidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:17716689, PubMed:25258363, PubMed:7862533). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may a

LOCALIZAÇÃO

NucleusNucleus, nucleolusCytoplasmNucleus speckleNucleus, nucleoplasm

VIAS BIOLÓGICAS (3)
Nephron developmentNegative Regulation of CDH1 Gene TranscriptionTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Frasier syndrome

Characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
109.7 TPM
Fallopian Tube
75.2 TPM
Ovário
65.2 TPM
Testículo
40.5 TPM
Adipose Visceral Omentum
30.0 TPM
OUTRAS DOENÇAS (12)
Wilms tumor 1nephrotic syndrome, type 4Meacham syndromemalignant mesothelioma
HGNC:12796UniProt:P19544
DAAM2Disheveled-associated activator of morphogenesis 2Candidate gene tested inAltamente restrito
FUNÇÃO

Key regulator of the Wnt signaling pathway, which is required for various processes during development, such as dorsal patterning, determination of left/right symmetry or myelination in the central nervous system. Acts downstream of Wnt ligands and upstream of beta-catenin (CTNNB1). Required for canonical Wnt signaling pathway during patterning in the dorsal spinal cord by promoting the aggregation of Disheveled (Dvl) complexes, thereby clustering and formation of Wnt receptor signalosomes and p

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Nephrotic syndrome 24

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS24 is an autosomal recessive, slowly progressive form. Most patients eventually develop end-stage renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
162.0 TPM
Brain Spinal cord cervical c-1
147.2 TPM
Esôfago - Junção
128.3 TPM
Substância negra
94.9 TPM
Artéria tibial
87.6 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 24familial idiopathic steroid-resistant nephrotic syndrome
HGNC:18143UniProt:Q86T65
LAMA5Laminin subunit alpha-5Candidate gene tested inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Plays a role in the regulation of skeletogenesis, through a mechanism that involves integrin-mediated signaling and PTK2B/PYK2 (PubMed:33242826)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (9)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactionsNon-integrin membrane-ECM interactions
MECANISMO DE DOENÇA

Nephrotic syndrome 26

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS26 is an autosomal recessive form characterized by onset of proteinuria in the first months or years of life. Some patients respond to steroids, whereas others show steroid resistance and progression to end-stage renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
175.2 TPM
Artéria tibial
171.8 TPM
Cerebelo
127.8 TPM
Artéria coronária
127.2 TPM
Pulmão
125.9 TPM
OUTRAS DOENÇAS (4)
nephrotic syndrome, IIa 26bent bone dysplasia syndrome 2LAMA5-related multisystemic syndromefamilial idiopathic steroid-resistant nephrotic syndrome
HGNC:6485UniProt:O15230
TBC1D8BTBC1 domain family member 8BCandidate gene tested inTolerante
FUNÇÃO

Involved in vesicular recycling, probably as a RAB11B GTPase-activating protein

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Nephrotic syndrome 20

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS20 is an X-linked, steroid-resistant form with onset at birth or in the first years of life in affected males. Death in childhood may occur in absence of renal transplantation. Carrier females may be unaffected or have a mild disease with proteinuria.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
11.7 TPM
Fibroblastos
11.7 TPM
Pituitária
7.7 TPM
Tireoide
5.4 TPM
Cervix Ectocervix
5.0 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 20familial idiopathic steroid-resistant nephrotic syndrome
HGNC:24715UniProt:Q0IIM8
NUP160Nuclear pore complex protein Nup160Candidate gene tested inRestrito
FUNÇÃO

Functions as a component of the nuclear pore complex (NPC) (PubMed:11564755, PubMed:11684705). Involved in poly(A)+ RNA transport

LOCALIZAÇÃO

Nucleus, nuclear pore complex

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Nephrotic syndrome 19

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS19 is an autosomal recessive, steroid-resistant form with onset in the first or second decade of life, resulting in chronic kidney disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
35.8 TPM
Ovário
31.4 TPM
Fibroblastos
28.6 TPM
Útero
27.1 TPM
Nervo tibial
27.1 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 19familial idiopathic steroid-resistant nephrotic syndrome
HGNC:18017UniProt:Q12769
ANLNAnillinCandidate gene tested inRestrito
FUNÇÃO

Required for cytokinesis (PubMed:16040610). Essential for the structural integrity of the cleavage furrow and for completion of cleavage furrow ingression. Plays a role in bleb assembly during metaphase and anaphase of mitosis (PubMed:23870127). May play a significant role in podocyte cell migration (PubMed:24676636)

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeletonCytoplasm, cell cortexCell projection, bleb

VIAS BIOLÓGICAS (3)
RHOB GTPase cycleRHOC GTPase cycleRHOA GTPase cycle
MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 8

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

OUTRAS DOENÇAS (2)
focal segmental glomerulosclerosis 8familial idiopathic steroid-resistant nephrotic syndrome
HGNC:14082UniProt:Q9NQW6
CD2APCD2-associated proteinCandidate gene tested inTolerante
FUNÇÃO

Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton (PubMed:10339567). In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity). May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By simil

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell projection, ruffleCell junction

VIAS BIOLÓGICAS (1)
Nephrin family interactions
MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 3

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

OUTRAS DOENÇAS (2)
focal segmental glomerulosclerosis 3, susceptibility tofamilial idiopathic steroid-resistant nephrotic syndrome
HGNC:14258UniProt:Q9Y5K6
NUP133Nuclear pore complex protein Nup133Candidate gene tested inRestrito
FUNÇÃO

Involved in poly(A)+ RNA transport. Involved in nephrogenesis (PubMed:30179222)

LOCALIZAÇÃO

Nucleus, nuclear pore complexChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (10)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Nephrotic syndrome 18

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS18 is an autosomal recessive, steroid-resistant progressive form with onset in the first decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
35.8 TPM
Ovário
33.2 TPM
Cérebro - Hemisfério cerebelar
33.0 TPM
Útero
31.8 TPM
Cerebelo
31.0 TPM
OUTRAS DOENÇAS (4)
nephrotic syndrome, type 18Galloway-Mowat syndrome 8familial idiopathic steroid-resistant nephrotic syndromeGalloway-Mowat syndrome
HGNC:18016UniProt:Q8WUM0
CRB2Protein crumbs homolog 2Candidate gene tested inTolerante
FUNÇÃO

Apical polarity protein that plays a central role during the epithelial-to-mesenchymal transition (EMT) at gastrulation, when newly specified mesodermal cells move inside the embryo (By similarity). Acts by promoting cell ingression, the process by which cells leave the epithelial epiblast and move inside the embryo to form a new tissue layer (By similarity). The anisotropic distribution of CRB2 and MYH10/myosin-IIB at cell edges define which cells will ingress: cells with high apical CRB2 are p

LOCALIZAÇÃO

Apical cell membraneCytoplasmCell junctionSecreted

MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 9

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

OUTRAS DOENÇAS (3)
ventriculomegaly-cystic kidney diseasefocal segmental glomerulosclerosis 9familial idiopathic steroid-resistant nephrotic syndrome
HGNC:18688UniProt:Q5IJ48
AVILAdvillinCandidate gene tested inTolerante
FUNÇÃO

Ca(2+)-regulated actin-binding protein which plays an important role in actin bundling (PubMed:29058690). May have a unique function in the morphogenesis of neuronal cells which form ganglia. Required for SREC1-mediated regulation of neurite-like outgrowth. Plays a role in regenerative sensory axon outgrowth and remodeling processes after peripheral injury in neonates. Involved in the formation of long fine actin-containing filopodia-like structures in fibroblast. Plays a role in ciliogenesis. I

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell projection, lamellipodiumCell junction, focal adhesionCell projection, neuron projectionCell projection, axon

MECANISMO DE DOENÇA

Nephrotic syndrome 21

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS21 is an autosomal recessive, rapidly progressive, steroid-resistant form characterized by onset of kidney dysfunction in the first year of life. Some patients may have variable extra-renal manifestations.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 21familial idiopathic steroid-resistant nephrotic syndrome
HGNC:14188UniProt:O75366
GAPVD1GTPase-activating protein and VPS9 domain-containing protein 1Candidate gene tested inAltamente restrito
FUNÇÃO

Acts both as a GTPase-activating protein (GAP) and a guanine nucleotide exchange factor (GEF), and participates in various processes such as endocytosis, insulin receptor internalization or LC2A4/GLUT4 trafficking. Acts as a GEF for the Ras-related protein RAB31 by exchanging bound GDP for free GTP, leading to regulate LC2A4/GLUT4 trafficking. In the absence of insulin, it maintains RAB31 in an active state and promotes a futile cycle between LC2A4/GLUT4 storage vesicles and early endosomes, ret

LOCALIZAÇÃO

MembraneEndosome

VIAS BIOLÓGICAS (2)
Clathrin-mediated endocytosisRAB GEFs exchange GTP for GDP on RABs
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
18.3 TPM
Tireoide
17.8 TPM
Nervo tibial
16.8 TPM
Skin Sun Exposed Lower leg
16.4 TPM
Pulmão
16.1 TPM
OUTRAS DOENÇAS (1)
familial idiopathic steroid-resistant nephrotic syndrome
HGNC:23375UniProt:Q14C86
NPHS1NephrinCandidate gene tested inTolerante
FUNÇÃO

Seems to play a role in the development or function of the kidney glomerular filtration barrier. Regulates glomerular vascular permeability. May anchor the podocyte slit diaphragm to the actin cytoskeleton. Plays a role in skeletal muscle formation through regulation of myoblast fusion (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Nephrin family interactions
MECANISMO DE DOENÇA

Nephrotic syndrome 1

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
36.8 TPM
Pâncreas
15.9 TPM
Rim - Medula
3.1 TPM
Testículo
2.3 TPM
Cerebelo
0.7 TPM
OUTRAS DOENÇAS (2)
congenital nephrotic syndrome, Finnish typefamilial idiopathic steroid-resistant nephrotic syndrome
HGNC:7908UniProt:O60500
PAX2Paired box protein Pax-2Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that may have a role in kidney cell differentiation (PubMed:24676634). Has a critical role in the development of the urogenital tract, the eyes, and the CNS

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Formation of the ureteric budFormation of the nephric ductFormation of intermediate mesoderm
MECANISMO DE DOENÇA

Papillorenal syndrome

An autosomal dominant disorder characterized by both ocular and renal anomalies, but may also include vesicoureteral reflux, high frequency hearing loss, central nervous system anomalies, and/or genital anomalies. Eye anomalies in this disorder consist of a wide and sometimes excavated dysplastic optic disk with the emergence of the retinal vessels from the periphery of the disk, designated optic nerve coloboma or 'morning glory' anomaly. Associated findings may include a small corneal diameter, retinal coloboma, scleral staphyloma, optic nerve cyst, microphthalmia, and pigmentary macular dysplasia. The kidneys are small and abnormally formed (renal hypodysplasia), and have fewer than the normal number of glomeruli, which are enlarged (oligomeganephronia). These ocular and renal anomalies result in decreased visual acuity and retinal detachment, as well as hypertension, proteinuria, and renal insufficiency that frequently progresses to end-stage renal disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
58.0 TPM
Rim - Córtex
52.8 TPM
Fallopian Tube
3.5 TPM
Cerebelo
2.5 TPM
Cérebro - Hemisfério cerebelar
1.8 TPM
OUTRAS DOENÇAS (4)
renal coloboma syndromefocal segmental glomerulosclerosis 7familial idiopathic steroid-resistant nephrotic syndromerenal hypoplasia, bilateral
HGNC:8616UniProt:Q02962
ARHGAP24Rho GTPase-activating protein 24Candidate gene tested inTolerante
FUNÇÃO

Rho GTPase-activating protein involved in cell polarity, cell morphology and cytoskeletal organization. Acts as a GTPase activator for the Rac-type GTPase by converting it to an inactive GDP-bound state. Controls actin remodeling by inactivating Rac downstream of Rho leading to suppress leading edge protrusion and promotes cell retraction to achieve cellular polarity. Able to suppress RAC1 and CDC42 activity in vitro. Overexpression induces cell rounding with partial or complete disruption of ac

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, adherens junctionCell junction, focal adhesionCell projection

VIAS BIOLÓGICAS (3)
RAC1 GTPase cycleCDC42 GTPase cycleRHOA GTPase cycle
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
familial idiopathic steroid-resistant nephrotic syndrome
HGNC:25361UniProt:Q8N264
EMP2Epithelial membrane protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as a key regulator of cell membrane composition by regulating protein surface expression. Also, plays a role in regulation of processes including cell migration, cell proliferation, cell contraction and cell adhesion. Regulates transepithelial migration of neutrophils into the alveolar lumen, potentially via mediation of cell surface expression of adhesion markers and lipid raft formation (By similarity). Negatively regulates caveolae formation by reducing CAV1 expression and CAV1 amou

LOCALIZAÇÃO

Golgi apparatus membraneCell membraneApical cell membraneMembrane raftCytoplasmNucleusCytoplasm, perinuclear region

MECANISMO DE DOENÇA

Nephrotic syndrome 10

A form of nephrotic syndrome, a renal disease clinically characterized by focal segmental glomerulosclerosis, progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. NPHS10 is a steroid-sensitive form characterized by onset in childhood and remission without end-stage kidney disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
271.7 TPM
Skin Not Sun Exposed Suprapubic
123.1 TPM
Esôfago - Mucosa
115.5 TPM
Skin Sun Exposed Lower leg
107.8 TPM
Aorta
97.9 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 10familial idiopathic steroid-resistant nephrotic syndrome
HGNC:3334UniProt:P54851
NUP205Nuclear pore complex protein Nup205Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance (PubMed:9348540). May anchor NUP62 and other nucleoporins, but not NUP153 and TPR, to the NPC (PubMed:15229283). In association with TMEM209, may be involved in nuclear transport of various nuclear proteins in addition to MYC (PubMed:22719065)

LOCALIZAÇÃO

Nucleus membraneNucleus, nuclear pore complex

VIAS BIOLÓGICAS (10)
snRNP AssemblyHCMV Early EventsHCMV Late EventsNEP/NS2 Interacts with the Cellular Export MachineryTransport of Ribonucleoproteins into the Host Nucleus
MECANISMO DE DOENÇA

Nephrotic syndrome 13

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
70.9 TPM
Fibroblastos
32.1 TPM
Útero
31.0 TPM
Fallopian Tube
30.1 TPM
Nervo tibial
28.0 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 13familial idiopathic steroid-resistant nephrotic syndrome
HGNC:18658UniProt:Q92621
COQ6Ubiquinone biosynthesis monooxygenase COQ6, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

FAD-dependent monooxygenase required for two non-consecutive steps during ubiquinone biosynthesis (PubMed:26260787, PubMed:38425362). Required for the C5-ring hydroxylation during ubiquinone biosynthesis by catalyzing the hydroxylation of 4-hydroxy-3-(all-trans-decaprenyl)benzoic acid to 3,4-dihydroxy-5-(all-trans-decaprenyl)benzoic acid (PubMed:26260787, PubMed:38425362). Also acts downstream of COQ4, for the C1-hydroxylation during ubiquinone biosynthesis by catalyzing the hydroxylation of 2-m

LOCALIZAÇÃO

Mitochondrion inner membraneGolgi apparatusCell projection

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 6

An autosomal recessive disorder characterized by onset in infancy of severe progressive nephrotic syndrome resulting in end-stage renal failure and sensorineural deafness. Renal biopsy usually shows focal segmental glomerulosclerosis.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
familial steroid-resistant nephrotic syndrome with sensorineural deafnessschwannomatosis
HGNC:20233UniProt:Q9Y2Z9
NPHS2PodocinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the regulation of glomerular permeability, acting probably as a linker between the plasma membrane and the cytoskeleton

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Nephrin family interactions
MECANISMO DE DOENÇA

Nephrotic syndrome 2

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. The disorder is resistant to steroid treatment and progresses to end-stage renal failure in the first or second decades. Some patients show later onset of the disorder.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
175.0 TPM
Rim - Medula
22.9 TPM
Testículo
3.1 TPM
Pituitária
0.5 TPM
Bladder
0.2 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 2familial idiopathic steroid-resistant nephrotic syndrome
HGNC:13394UniProt:Q9NP85
COQ8BAtypical kinase COQ8B, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:24270420, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (PubMed:38425362). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates a prenyl lipid in the ubiquinone biosynthesis pat

LOCALIZAÇÃO

Mitochondrion membraneCytoplasm, cytosolCell membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Nephrotic syndrome 9

A form of nephrotic syndrome, a renal disease clinically characterized by progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show focal segmental glomerulosclerosis.

VIAS REACTOME (1)
OUTRAS DOENÇAS (3)
nephrotic syndrome, type 9familial idiopathic steroid-resistant nephrotic syndromeretinitis pigmentosa
HGNC:19041UniProt:Q96D53
ARHGDIARho GDP-dissociation inhibitor 1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Controls Rho proteins homeostasis. Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Retains Rho proteins such as CDC42, RAC1 and RHOA in an inactive cytosolic pool, regulating their stability and protecting them from degradation. Actively involved in the recycling and distribution of activated Rho GTPases in the cell, mediates extraction from membranes of both inactive and activated molecules d

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (9)
Axonal growth inhibition (RHOA activation)Axonal growth stimulationRHOG GTPase cycleRHOH GTPase cycleRAC1 GTPase cycle
MECANISMO DE DOENÇA

Nephrotic syndrome 8

A form of nephrotic syndrome, a renal disease clinically characterized by progressive renal failure, severe proteinuria, hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show diffuse mesangial sclerosis, with small glomeruli, hypercellularity, increased extracellular matrix, and contracted/collapsed glomerular tufts surrounded by immature or abnormal podocytes.

OUTRAS DOENÇAS (2)
nephrotic syndrome, type 8familial idiopathic steroid-resistant nephrotic syndrome
HGNC:678UniProt:P52565
PLCE11-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. PLCE1 is a bifunctional enzyme which also regulates small GTPases of the Ras superfamily through its Ras guanine-exchange factor (RasGEF) activity. As an effector of heterotrimeric and small G-protein, it may play a role in cell survival, cell growth, actin organization and T-cell activation. In podocytes, is

LOCALIZAÇÃO

Cytoplasm, cytosolCell membraneGolgi apparatus membraneCell projection, lamellipodium

VIAS BIOLÓGICAS (1)
Synthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Nephrotic syndrome 3

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. Most patients with NPHS3 show diffuse mesangial sclerosis on renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes, thickened basement membranes, and diminished patency of the capillary lumen.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
22.9 TPM
Nervo tibial
16.9 TPM
Tireoide
13.1 TPM
Útero
12.8 TPM
Cólon transverso
12.4 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 3familial idiopathic steroid-resistant nephrotic syndrome
HGNC:17175UniProt:Q9P212
ACTN4Alpha-actinin-4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (PubMed:15772161). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recr

LOCALIZAÇÃO

NucleusCytoplasmCell junctionCytoplasm, cytoskeleton, stress fiberCytoplasm, perinuclear region

VIAS BIOLÓGICAS (1)
Nephrin family interactions
MECANISMO DE DOENÇA

Focal segmental glomerulosclerosis 1

A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation.

OUTRAS DOENÇAS (2)
focal segmental glomerulosclerosis 1familial idiopathic steroid-resistant nephrotic syndrome
HGNC:166UniProt:O43707
NUP93Nuclear pore complex protein Nup93Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance (PubMed:9348540). May anchor nucleoporins, but not NUP153 and TPR, to the NPC. During renal development, regulates podocyte migration and proliferation through SMAD4 signaling (PubMed:26878725)

LOCALIZAÇÃO

Nucleus membraneNucleus, nuclear pore complexNucleus envelope

VIAS BIOLÓGICAS (10)
snRNP AssemblyHCMV Early EventsHCMV Late EventsNEP/NS2 Interacts with the Cellular Export MachineryTransport of Ribonucleoproteins into the Host Nucleus
MECANISMO DE DOENÇA

Nephrotic syndrome 12

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. NPHS12 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
20.3 TPM
Linfócitos
19.2 TPM
Tireoide
16.2 TPM
Fibroblastos
12.9 TPM
Brain Spinal cord cervical c-1
12.1 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 12familial idiopathic steroid-resistant nephrotic syndrome
HGNC:28958UniProt:Q8N1F7
PTPROReceptor-type tyrosine-protein phosphatase UDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Tyrosine-protein phosphatase which dephosphorylates CTNNB1. Regulates CTNNB1 function both in cell adhesion and signaling. May function in cell proliferation and migration and play a role in the maintenance of epithelial integrity. May play a role in megakaryocytopoiesis

LOCALIZAÇÃO

Cell junctionCell membrane

VIAS BIOLÓGICAS (1)
Signaling by NTRK3 (TRKC)
VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
15.6 TPM
Brain Nucleus accumbens basal ganglia
9.8 TPM
Brain Frontal Cortex BA9
7.6 TPM
Aorta
7.5 TPM
Córtex cerebral
6.2 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 6familial idiopathic steroid-resistant nephrotic syndrome
HGNC:9678UniProt:Q92729

Medicamentos aprovados (FDA)

3 medicamentos encontrados nos registros da FDA americana.

💊 Betaloan SUIK (BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE)
💊 Dyural 40 Kit (METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL)
💊 Dyural 80-LM (METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

128 variantes patogênicas registradas no ClinVar.

🧬 NUP107: NM_020401.4(NUP107):c.8+5G>C ()
🧬 NUP107: NM_020401.4(NUP107):c.1909A>T (p.Lys637Ter) ()
🧬 NUP107: NM_020401.4(NUP107):c.160C>T (p.Arg54Ter) ()
🧬 NUP107: GRCh37/hg19 12q15-21.1(chr12:68168330-72795051)x1 ()
🧬 NUP107: NM_020401.4(NUP107):c.2263-23G>T ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 9 variantes classificadas pelo ClinVar.

9
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
NPHS2: NM_014625.4(NPHS2):c.637G>A (p.Ala213Thr) [Likely pathogenic]
AXDND1: NM_014625.4(NPHS2):c.928G>A (p.Glu310Lys) [Pathogenic/Likely pathogenic]
NPHS2: NM_014625.4(NPHS2):c.506T>C (p.Leu169Pro) [Pathogenic]
NPHS2: NM_014625.4(NPHS2):c.714G>C (p.Arg238Ser) [Pathogenic/Likely pathogenic]
AXDND1: NM_014625.4(NPHS2):c.851C>T (p.Ala284Val) [Pathogenic/Likely pathogenic]

Vias biológicas (Reactome)

84 vias biológicas associadas aos genes desta condição.

ISG15 antiviral mechanism Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Transport of the SLBP independent Mature mRNA Transport of the SLBP Dependant Mature mRNA Transport of Mature mRNA Derived from an Intronless Transcript Transport of Mature mRNA derived from an Intron-Containing Transcript Rev-mediated nuclear export of HIV RNA Transport of Ribonucleoproteins into the Host Nucleus NS1 Mediated Effects on Host Pathways Viral Messenger RNA Synthesis NEP/NS2 Interacts with the Cellular Export Machinery Regulation of Glucokinase by Glucokinase Regulatory Protein Nuclear import of Rev protein Vpr-mediated nuclear import of PICs snRNP Assembly Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion SUMOylation of DNA damage response and repair proteins SUMOylation of ubiquitinylation proteins Nuclear Pore Complex (NPC) Disassembly Regulation of HSF1-mediated heat shock response SUMOylation of SUMOylation proteins SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA replication proteins Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) RHO GTPases Activate Formins tRNA processing in the nucleus Mitotic Prometaphase HCMV Early Events Scavenging of heme from plasma Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Nephrin family interactions RHOD GTPase cycle Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels TRP channels Role of second messengers in netrin-1 signaling Collagen degradation Fibronectin matrix formation Collagen biosynthesis and modifying enzymes Signaling by PDGF Assembly of collagen fibrils and other multimeric structures Integrin cell surface interactions Anchoring fibril formation Crosslinking of collagen fibrils Laminin interactions Non-integrin membrane-ECM interactions ECM proteoglycans NCAM1 interactions Collagen chain trimerization Attachment of bacteria to epithelial cells Transcriptional regulation of testis differentiation Negative Regulation of CDH1 Gene Transcription Nephron development Degradation of the extracellular matrix Interleukin-4 and Interleukin-13 signaling MET activates PTK2 signaling Formation of the dystrophin-glycoprotein complex (DGC) Developmental Lineage of Pancreatic Ductal Cells Golgi Associated Vesicle Biogenesis RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle Clathrin-mediated endocytosis RAB GEFs exchange GTP for GDP on RABs Formation of intermediate mesoderm Formation of the nephric duct Formation of the ureteric bud CDC42 GTPase cycle RAC1 GTPase cycle HCMV Late Events Postmitotic nuclear pore complex (NPC) reformation SARS-CoV-2 activates/modulates innate and adaptive immune responses Ubiquinol biosynthesis Axonal growth inhibition (RHOA activation) Axonal growth stimulation RAC2 GTPase cycle RHOH GTPase cycle RHOG GTPase cycle Synthesis of IP3 and IP4 in the cytosol Platelet degranulation Signaling by SCF-KIT

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado2
3Fase 33
2Fase 23
·Pré-clínico12
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome nefrótica idiopática

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

54 ensaios clínicos encontrados, 12 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
674 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 674

#1

Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.

The Lancet. Child &amp; adolescent health2026 Mar 16

Prolonged glucocorticoid therapy is the standard initial treatment for idiopathic nephrotic syndrome in children, but is associated with marked toxic effects. We aimed to assess whether a novel treatment protocol with mycophenolate mofetil is as effective as standard therapy with prednisone, while reducing the burden of glucocorticoid-related side-effects. INTENT was a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial done in 37 community, municipal, and university hospitals in Germany. Patients aged 1-10 years with a first episode of steroid-sensitive nephrotic syndrome were randomly assigned (1:1) by a centralised web-based tool to receive either mycophenolate mofetil or prednisone (standard treatment), after remission induced by prednisone or prednisolone at a dose of 60 mg/m2 body surface area (maximum 80 mg/day) within 28 days. Block randomisation (block size of eight) was stratified by age (<7 years or ≥7 years). Mycophenolate mofetil was given at 1200 mg/m2 body surface area per day, twice daily, as a suspension (200 mg/mL) for a total treatment duration of 12 weeks. Prednisone was administered once, twice, or three times daily for 6 weeks at 60 mg/m2 body surface area per day (maximum 80 mg). Thereafter, prednisone was given for a further 6 weeks at 40 mg/m2 body surface area (maximum 60 mg) once daily in the morning on alternate days. The primary endpoint was the occurrence of a treated relapse during the 24-months of follow-up in the modified intention-to-treat population. The non-inferiority margin was 15%. This trial is registered with the European Union Drug Regulating Authorities Clinical Trials database (EudraCT 2014-001991-76) and has been completed. Between Oct 12, 2015, and April 23, 2021, 497 patients were screened for eligibility, 272 of whom were randomly assigned (136 to each group). The modified intention-to-treat population comprised 269 patients, of whom 173 (64%) were boys and 96 (36%) were girls (median age 4·0 years [IQR 2·0-5·0]). Mycophenolate mofetil was non-inferior to prednisone for the primary endpoint of treated relapse (106 [79·1%] of 134 vs 101 [74·8%] of 135; difference 4·3% [90% CIs -4·2 to 12·7]; p=0·019). At the end of the first 12 weeks of treatment, fewer glucocorticoid-related side-effects were observed in the mycophenolate mofetil group than the prednisone group, including arterial hypertension (78 [59·1%] of 132 vs 115 [87·1%] of 132; difference -28·0% [95% CI -37·7 to -17·5]), lower BMI (BMI Z score 0·16 [SD 0·85] vs 1·41 [1·02]; difference -1·24 [-1·47 to -1·02]), and fewer psychological abnormalities (37 [27·8%] of 133 vs 77 [57·9%] of 133; difference -30·1% [-40·9 to -18·4]). More patients in the mycophenolate mofetil group than in the prednisone group developed infections (93 [69·9%] of 133 vs 74 [55·6%] of 133; difference 14·3% [2·7 to 25·5]) and there was no statistically significant difference in the number of patients who developed at least one gastrointestinal disorder (22 [16·5%] of 133 vs 13 [9·8%] of 133; difference 6·8% [-1·5 to 14·8]). Our findings suggest that mycophenolate mofetil is non-inferior to standard prednisone treatment, with reduced glucocorticoid-related toxic effects. These findings could modify the initial standard of care for patients with steroid-sensitive nephrotic syndrome. German Federal Ministry of Education and Research.

#2

Role of renal doppler in children with idiopathic nephrotic syndrome.

BMC pediatrics2026 Feb 03

Renal Doppler can measure intrarenal vascular resistance and may help determine the degree of intrarenal damage, as well as predict subsequent kidney function impairment. However, its utility in children with an underlying kidney disease such as nephrotic syndrome has not been widely examined. This work aimed to measure serial renal resistive index (RI) in pediatric patients with idiopathic nephrotic syndrome to assess its predictive value for steroid resistance and disease outcome. This prospective cohort study included 60 patients with idiopathic nephrotic syndrome aged 5 to < 18 years. Renal Doppler was performed on all children, and renal RI was measured at diagnosis, after 1, 3, and 6 months of diagnosis. The average interlobar renal RI of the right and left kidneys at diagnosis, during follow-up at 1, 3, and 6 months, was significantly higher in steroid-resistant nephrotic syndrome than in the steroid-sensitive nephrotic syndrome. Meanwhile, the estimated glomerular filtration rate (GFR) was significantly lower in steroid-resistant nephrotic syndrome than in steroid-sensitive nephrotic syndrome after 6 months, with no significant difference at diagnosis, after 1 month, or 3 months. The average interlobar RI at diagnosis can predict steroid resistance at a cutoff > 0.60 with 92.31% sensitivity and 85.32% specificity. Moreover, the average interlobar RI after 3 months of follow-up can predict short disease outcome at a cutoff > 0.63 with 84.62% sensitivity and 82.98% specificity. Renal RI might be an effective non-invasive tool for early prediction and risk stratification of steroid resistance in pediatric patients with idiopathic nephrotic syndrome. Its utility lies in supporting earlier clinical decisions rather than replacing established diagnostic methods.

#3

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Science translational medicine2026 Jan 14

Idiopathic nephrotic syndrome (INS) is a podocyte disease triggered by immune-derived factors. Endothelial activation occurs in this context, but whether the activated endothelium contributes to podocyte injury is unknown. We tested the hypothesis that CD93, a protein primarily expressed in the endothelium, is a contributory factor of podocyte injury. We studied 460 patients with INS and 150 with other podocytopathies. CD93 was analyzed in kidney tissue, urine, and serum samples. We tested the efficacy of CD93 blockade in vitro and in vivo and investigated the relationship between soluble CD93 and clinical outcomes in human INS. CD93 was highly expressed by glomerular endothelial cells (GEnCs) in human INS, and INS sera stimulated cultured human GEnCs to release CD93. Mechanistically, soluble CD93 mediated podocyte activation via β1 integrin/FAK signaling in cultured human podocytes. CD93 blockade mitigated the activation of cultured human podocytes and albumin permeability in human GEnC-podocyte cocultures as well as albuminuria, glomerulosclerosis, and podocyte loss in two models of nephrotic syndrome: podocyte-specific transforming growth factor-β1 signaling (PodTgfbr1) mice and adriamycin-treated mice. Cd93 knockout mice showed less proteinuria and glomerulosclerosis, compared with controls, after adriamycin injection. In patients with INS, soluble CD93 was high in urine in ~90% and 50% of patients in relapse and remission, respectively. High urinary CD93 was associated with faster decline in kidney function and slower response to immunosuppression. Soluble and glomerular CD93 was also elevated in other podocytopathies. We conclude that soluble CD93 contributes to podocyte injury.

#4

Factors Influencing Cyclosporine Trough and Two-Hour Post-dose Concentrations in Children with Idiopathic Nephrotic Syndrome.

Indian pediatrics2026 Jan

To determine the cyclosporine trough (C0) and two-hour post-dose concentrations (C2) in children with nephrotic syndrome (NS) and study the factors influencing them. In this ambispective cohort study, children with NS (including frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome) on cyclosporine therapy were enrolled. Clinical and laboratory data were recorded. C0 and C2 were estimated using liquid chromatography mass spectrometry. Among 27 patients with a mean (SD) age of 6.4 (4.1) years, the median (Q1, Q3) of C0 and C2 were 114.8 (86.1, 186.3) ng/mL and 661.6 (442.1, 884.6) ng/mL, respectively. At a mean (SD) cyclosporine dose of 4.1 (0.8) mg/kg/day, 12 (44%) patients had C0 above and 4 (15%) below the therapeutic range (80-120 ng/mL). C2 levels were outside the recommended ranges in 17 (63%) children, within range in 7 (26%), and below in 3 (11%). Capsule users had higher C0 than syrup users. Amlodipine therapy was associated with higher C0 levels. Nearly half the children had C0 and C2 levels outside the therapeutic range. Dosage form and amlodipine influenced C0, not C2 concentrations.

#5

Inferior Vena Cava/Aorta Diameter Index for the Evaluation of Intravascular Volume Status in Children with Idiopathic Nephrotic Syndrome.

Indian pediatrics2026 Feb

To correlate the inferior vena cava/aorta diameter (IVC/Ao index) in children with nephrotic syndrome with clinical indicators of volume status, and to compare the IVC/Ao index between children in relapse and in remission. This prospective longitudinal study included children aged 2-18 years presenting with relapsed nephrotic syndrome. Low intravascular volume status was diagnosed if two of the three criteria (tachycardia, hypotension, prolonged capillary filling time) were present. Sonographic measurements of the IVC and aorta diameter were obtained by a single observer at recruitment and after achieving remission. One hundred and three children (73 boys) with a median (Q1, Q3) age 72 (24, 216) months were recruited. 26 (25%) children had low intravascular volume at recruitment. The mean (SD) IVC/Ao index was lower in low volume status compared to normal volume status [0.74 (0.2) vs 0.83 (0.1); P = 0.090]. The correlation between IVC/Ao index and heart rate (r = -0.29, P = 0.003) and mean arterial pressure (r = 0.23, P = 0.018) was weak. IVC/Ao index was not an independent predictor of volume status (OR = 0.04, P = 0.331). The mean (SD) IVC/Ao index increased significantly from when in relapse to remission [0.94 (0.1) vs 1.05 (0.2), respectively; P = 0.001]. The IVC/Ao index was lower in relapse than in remission, and did not predict low intravascular volume status independently.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC958 artigos no totalmostrando 195

2026

B cell depletion with rituximab in children with steroid-sensitive nephrotic syndrome: does depletion duration change outcome?

Pediatric nephrology (Berlin, Germany)
2026

Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.

The Lancet. Child &amp; adolescent health
2026

A Retrospective Cohort Analysis of Short-Term Outcomes of the Mycophenolate Mofetil-Based Triple Regimen for the Treatment of Calcineurin Inhibitor-Resistant Childhood Nephrotic Syndrome: A Single-Center Experience.

Cureus
2026

Unraveling BCR Repertoire Diversity and its Impact on Glucocorticoid Therapy in Pediatric Idiopathic Nephrotic Syndrome.

Journal of clinical immunology
2026

Anti-nephrin autoantibodies in post-transplant recurrent focal segmental glomerulosclerosis: diagnostic advances and future directions.

Clinical and experimental nephrology
2026

Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.

Kidney international reports
2026

Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease.

BMC nephrology
2026

Steroid-induced adrenal insufficiency in children with nephrotic syndrome: a systematic review.

Pediatric nephrology (Berlin, Germany)
2026

Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.

Kidney medicine
2026

Efficacy and Safety of Therapies for Pediatric Steroid-Resistant Idiopathic Nephrotic Syndrome: A Systematic Review of the Last Decade.

Cureus
2026

Single relapse at ≥ 0.5 mg/kg alternate-day prednisone predicts course of childhood nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2026

Role of renal doppler in children with idiopathic nephrotic syndrome.

BMC pediatrics
2026

Polygenic risk score from steroid-sensitive nephrotic syndrome GWAS indicates overlapping genetic basis with steroid-resistant cases.

Scientific reports
2026

Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death.

JCI insight
2026

A New Hope for Treating Podocytopathies: Emerging Role of Anti-Nephrin Antibody.

Clinical journal of the American Society of Nephrology : CJASN
2026

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Science translational medicine
2026

Association between Anti-Nephrin Antibodies and Podocytopathies: A Systematic Review and Meta-Analysis.

Nephron
2026

Celiac Disease in Children with Idiopathic Nephrotic Syndrome-A Retrospective Cohort Study.

Journal of clinical medicine
2025

Dynamic Changes in Oxidative Stress Biomarkers in a Child with Idiopathic Nephrotic Syndrome: A Longitudinal Case Study.

International journal of molecular sciences
2026

Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.

Kidney medicine
2026

B-cell activation underpins Rituximab response in focal segmental glomerulosclerosis.

Translational research : the journal of laboratory and clinical medicine
2025

Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up.

Frontiers in immunology
2025

Therapeutic trough mycophenolic acid levels positively correlate with omega-3 fatty acids in leukocytes of children with idiopathic nephrotic syndrome. a pilot study.

Frontiers in pharmacology
2025

Vitamin D Deficiency in Relapsing Idiopathic Nephrotic Syndrome in Children: Prevalence, Correlates, and Therapeutic Implications.

International journal of endocrinology
2025

Serum Podocalyxin Level as a Potential Biomarker for Diagnosis of Nephrotic Syndrome and Prediction of Steroid Response.

Medeniyet medical journal
2025

Afucosylated IgG in idiopathic nephrotic syndrome patients with anti-nephrin autoantibodies correlate with disease activity.

Journal of translational autoimmunity
2026

Identification of Potential Focal Segmental Glomerulosclerosis (FSGS) Through Evaluation of Parietal Epithelial Cells Status Changes Using Integrin α3 Immunostaining.

Laboratory investigation; a journal of technical methods and pathology
2025

Daratumumab combined with anti-CD20 therapy in pediatric and adult refractory idiopathic nephrotic syndrome: single-center experience.

Frontiers in immunology
2025

Comparative analysis of the bone age of wrist bones in Chinese children with different causes of short stature and central precocious puberty.

Quantitative imaging in medicine and surgery
2025

Seroconversion following varicella vaccination in children and adolescents with nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2025

Blood biomarkers of disease activity in pediatric idiopathic nephrotic syndrome: A prospective study.

Clinical nephrology
2025

Pneumococcal Vaccine Use and Immunogenicity in Patients with Glomerular Disease: A Scoping Review and Analysis of Healthcare Claims Data.

Glomerular diseases
2025

Machine learning model for predicting severe infection in children with idiopathic nephrotic syndrome: multicenter retrospective study.

Italian journal of pediatrics
2025

Vitamin D Status and Clinical Outcomes in Pediatric Idiopathic Nephrotic Syndrome: A Prospective Observational Study from North India.

Annals of African medicine
2026

Urinary vitamin D binding protein levels in children with idiopathic nephrotic syndrome: a biomarker differentiating steroid sensitive from steroid resistant nephrotic syndrome.

Jornal brasileiro de nefrologia
2026

Immunogenicity of the 23-valent polysaccharide pneumococcal vaccine in children with steroid sensitive nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2025

Obinutuzumab as a therapeutic option for SDNS children resistant to rituximab with anti-RTX antibodies.

Pediatric nephrology (Berlin, Germany)
2025

Modelling CubAm function and regulation in proximal tubular cells using iPSC-derived kidney organoids.

Experimental cell research
2025

Latent Intrarenal Renin-Angiotensin-Aldosterone System Activation Could Persist Until Early School-Aged in Children with a History of Low Birth Weight.

Biomarker insights
2025

Novel inflammation biomarkers in adult minimal change disease: predicting steroid-resistance and relapse.

European journal of medical research
2025

Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review.

BMC nephrology
2025

Clinical characteristics of children with idiopathic nephrotic syndrome infected with SARS-CoV-2: a single-center retrospective cohort study.

BMC pediatrics
2025

Development and external validation of a machine learning-based predictive model for acute kidney injury in hospitalized children with idiopathic nephrotic syndrome.

BMC medical informatics and decision making
2026

Macrophage migration inhibitory factor and angiopoietin-like protein 4 as markers for steroid response in children with idiopathic nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2025

Effectiveness of Mycophenolate Mofetil Trough Level Monitoring in Children with Relapsing Nephrotic Syndrome.

Clinical journal of the American Society of Nephrology : CJASN
2025

Thymic Stromal Lymphopoietin May Induce Steroid Resistance in Minimal Change Disease.

Nephrology (Carlton, Vic.)
2026

Factors Influencing Cyclosporine Trough and Two-Hour Post-dose Concentrations in Children with Idiopathic Nephrotic Syndrome.

Indian pediatrics
2025

Long-term outcome of mycophenolate mofetil after a single dose of rituximab in childhood-onset refractory idiopathic nephrotic syndrome.

Clinical and experimental nephrology
2025

Correlation of Oxidative Stress Biomarkers with Activity of Pediatric Idiopathic Nephrotic Syndrome.

Biomedicines
2025

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.

Kidney international reports
2025

Non-invasive Diagnosis of Antinephrin-Associated Podocytopathy.

Kidney international reports
2025

Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome.

Kidney international reports
2025

Proteinuria and albuminuria prevalence in allergic children.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2025

Impact of autonomic dysfunction in light chain amyloidosis patient with nephrotic syndrome and cardiac involvement.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
2026

Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors.

Journal of the American Society of Nephrology : JASN
2025

Co-localization of IgG with nephrin in immune-mediated idiopathic nephrotic syndrome.

Clinical and experimental nephrology
2026

Inferior Vena Cava/Aorta Diameter Index for the Evaluation of Intravascular Volume Status in Children with Idiopathic Nephrotic Syndrome.

Indian pediatrics
2025

Management of Nephrotic Syndrome in Pediatric Patients Treated by Different Steroid Regimens.

Medicina (Kaunas, Lithuania)
2025

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome.

Kidney international reports
2025

Kidney function and mortality in childhood nephrotic syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2025

Optimizing the use of anti-CD20 in childhood idiopathic nephrotic syndrome: an intersection of art and science.

Kidney international
2025

Machine learning using serial changes in proteinuria during initial steroid therapy to predict treatment response and immunosuppressant use in pediatric idiopathic nephrotic syndrome.

Clinical and experimental nephrology
2025

Autoantibodies Targeting Vinculin Reveal Novel Insight into the Mechanisms of Autoimmune Podocytopathies.

Research (Washington, D.C.)
2025

Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome.

Clinical and experimental nephrology
2025

Single cell analysis identified IFN signaling activation contributes to the pathogenesis of pediatric steroid-sensitive nephrotic syndrome.

Biomarker research
2025

Association between SIRT-1 and SERPINA4 gene polymorphisms and the risk of idiopathic nephrotic syndrome among Egyptian children.

Molecular biology reports
2025

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases.

Clinical kidney journal
2025

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

The Cochrane database of systematic reviews
2025

The efficacy and safety of rituximab monotherapy in the new onset pediatric idiopathic nephrotic syndrome: a randomized controlled clinical trial.

Renal failure
2025

Anti-CD20 monoclonal antibodies for idiopathic nephrotic syndrome: Advances, challenges, and future directions.

Pediatric nephrology (Berlin, Germany)
2025

Slowly Progressive Type 1 Diabetes following Steroid-Sensitive Relapsing Nephrotic Syndrome in Childhood: A Case Report.

Biomedicine hub
2025

Unraveling the Immunogenetic Mechanisms of Childhood Idiopathic Nephrotic Syndrome.

The Journal of pediatrics
2025

Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria.

Journal of the American Society of Nephrology : JASN
2025

Salivary Interleukin-6 and Interleukin-18 Levels and Their Association with Dental Health in Children with Idiopathic Nephrotic Syndrome.

International journal of molecular sciences
2025

Effects of steroid-resistant nephrotic syndrome serum on AA pathway in podocytes cultured in 3D in vitro glomerular model.

Scientific reports
2025

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies.

Kidney international reports
2025

[The highlights of nephrology in 2024].

Nephrologie &amp; therapeutique
2025

Anti-GAD antibody-negative, anti-IA2 antibody-positive slowly progressive insulin-dependent diabetes mellitus and Graves' disease preceded by childhood-onset minimal change nephrotic syndrome: a case report.

Diabetology international
2025

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature.

Renal failure
2025

Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients.

Pediatric nephrology (Berlin, Germany)
2025

A case of acute appendicitis in a patient with minimal change disease.

CEN case reports
2025

Different profiles of fatty acids between leukocytes and whole blood in children with idiopathic nephrotic syndrome.

Lipids in health and disease
2025

Amino acid variants in the HLA-DQA1 and HLA-DQB1 molecules explain the major association of variants with relapse status in pediatric patients with steroid-sensitive nephrotic syndrome.

Italian journal of pediatrics
2025

A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapy.

Clinical and experimental nephrology
2025

Quality of Life of Children with Idiopathic Nephrotic Syndrome.

Indian journal of nephrology
2025

Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2025

A "Trial within a Cohort" platform for pediatric clinical trials on idiopathic nephrotic syndrome: scope, objectives, and design of the retrospective-prospective cohort PIN'SNP.

Pediatric nephrology (Berlin, Germany)
2025

The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children.

Current issues in molecular biology
2024

Proteomic profiling of kidney biopsies in nephrotic syndrome.

Wellcome open research
2025

Detection of Antinephrin Antibodies in Childhood Idiopathic Nephrotic Syndrome.

Kidney international reports
2025

Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome.

Clinica chimica acta; international journal of clinical chemistry
2025

Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review.

PloS one
2025

Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2025

Changes in Serum Immunoglobulin Levels Play as Predictors of Treatment Response and Prognosis in Pediatric Idiopathic Nephrotic Syndrome During the Remission Phase.

Immunity, inflammation and disease
2024

Retrospective Cohort Analysis of Class II Human Leukocyte Antigen (HLA) Alleles in Children With Steroid-Dependent Nephrotic Syndrome Treated With Cyclophosphamide.

Cureus
2024

Kinetic-pharmacodynamic model to predict post-rituximab B-cell repletion as a predictor of relapse in pediatric idiopathic nephrotic syndrome.

Frontiers in pharmacology
2024

Analysis of Glomerular Transcriptomes from Nephrotic Patients Suggest APOL1 Risk Variants Impact Parietal Epithelial Cells.

medRxiv : the preprint server for health sciences
2025

Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome.

Clinical kidney journal
2024

Heat shock protein 70 levels in children with nephrotic syndrome.

The Turkish journal of pediatrics
2025

Successful Switch to Obinutuzumab in a Rituximab-Intolerant Child with Difficult-to-Treat Idiopathic Nephrotic Syndrome.

Journal of clinical medicine
2024

Management and Treatment of Primary Membranous Nephropathy With a Positive PLA2R Marker.

Cureus
2025

IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19.

Pediatric nephrology (Berlin, Germany)
2025

Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines.

Pediatric nephrology (Berlin, Germany)
2024

Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan.

World journal of nephrology
2025

Stem Cells Derived From Human Deciduous Exfoliated Teeth Ameliorate Adriamycin-induced Nephropathy In Rats By Modulating The Th17/Treg Balance.

Current stem cell research &amp; therapy
2025

Publisher Correction: Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.

Pediatric nephrology (Berlin, Germany)
2024

Renal survival and treatment of adult patients with Primary Focal Segmental glomerulosclerosis: A historical cohort study of the National Greek Registry.

PloS one
2024

The Pathogenesis of Nephrotic Syndrome: A Perspective from B Cells.

Kidney diseases (Basel, Switzerland)
2025

MicroRNAs in idiopathic childhood nephrotic syndrome.

Clinical and experimental nephrology
2024

Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility.

International journal of molecular sciences
2025

The autoimmune architecture of childhood idiopathic nephrotic syndrome.

Kidney international
2024

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome.

Kidney international reports
2025

Gut dysbiosis as a susceptibility factor in childhood idiopathic nephrotic syndrome.

Pediatrics and neonatology
2024

Assessment of health-related quality of life of children with idiopathic nephrotic syndrome and their caregivers in China.

Health and quality of life outcomes
2024

Modeling a biofluid-derived extracellular vesicle surface signature to differentiate pediatric idiopathic nephrotic syndrome clinical subgroups.

Scientific reports
2025

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

Journal of the American Society of Nephrology : JASN
2025

Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024

Anti-Tumor Necrosis Factor Treatment for Glomerulopathy: Case Report and Review of Literature.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS
2025

Autoantibodies Targeting Proteasome Subunit Alpha Type 1 in Autoimmune Podocytopathies.

Journal of the American Society of Nephrology : JASN
2025

Resolution versus persistence of childhood idiopathic nephrotic syndrome-A population-based study.

Acta paediatrica (Oslo, Norway : 1992)
2025

Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment-still up to date?

Pediatric nephrology (Berlin, Germany)
2024

Exosomes secreted by podocytes regulate the differentiation of Th17/Treg cells in idiopathic nephrotic syndrome.

Heliyon
2025

To biopsy or not to biopsy a teenager with typical idiopathic nephrotic syndrome? Start steroids first.

Pediatric nephrology (Berlin, Germany)
2025

To biopsy or not to biopsy a teenager with idiopathic nephrotic syndrome? Biopsy first.

Pediatric nephrology (Berlin, Germany)
2024

Risk Factors for Idiopathic Nephrotic Syndrome Relapse in Pediatric Age.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
2024

Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.

Journal of nephrology
2024

Serum tumour necrosis factor-alpha as a marker of disease activity in children with nephrotic syndrome.

Journal of tropical pediatrics
2024

National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.

Clinical kidney journal
2024

Novel mutation patterns in children with steroid-resistant nephrotic syndrome.

Clinical kidney journal
2024

Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft.

Kidney international
2024

An Atypical Presentation of Fabry Disease in a Patient With Nephrotic Syndrome: A Case Report.

Cureus
2024

Association between serum albumin and body water using a bioelectrical impedance analyzer: a case report of longitudinal variation in a child with initial idiopathic nephrotic syndrome.

AME case reports
2024

B-cell repertoire and functions in idiopathic nephrotic syndrome: what to learn from single-cell RNA sequencing?

Kidney international
2024

Nephrotic syndrome associated with solid malignancies: a systematic review.

BMC nephrology
2024

Relation between interleukin-13 and annexin-V levels and carotid intima-media thickness in nephrotic syndrome.

Journal of circulating biomarkers
2024

Pediatric idiopathic nephrotic syndrome during COVID-19 omicron variant pandemic.

Pediatrics international : official journal of the Japan Pediatric Society
2024

Immunogenicity, Immunological Memory and Monitoring of Disease Activity Following an Anamnestic Immunization With the 13-Valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome.

Journal of the Pediatric Infectious Diseases Society
2024

Autoantibodies Targeting Nephrin in Podocytopathies.

The New England journal of medicine
2024

Steroid-Resistant Nephrotic Syndrome due to NPHS2 Variants Is Not Associated With Posttransplant Recurrence.

Kidney international reports
2024

Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications.

Journal of proteome research
2024

A Rare De Novo Mutation in the TRIM8 Gene in a 17-Year-Old Boy with Steroid-Resistant Nephrotic Syndrome: Case Report.

International journal of molecular sciences
2024

Pediatric frequent relapsing nephrotic syndrome with multiple cerebral infarctions accompanied by patent foramen ovale and cerebral venous sinus thrombosis: a case report.

BMC nephrology
2024

Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access.

Kidney international
2024

Comprehensive mapping of saliva by multiomics in children with idiopathic nephrotic syndrome.

Nephrology (Carlton, Vic.)
2024

A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood.

Frontiers in immunology
2024

Effect of proteinuria at relapse on shear wave velocity assessed using ultrasound elastography in children with idiopathic nephrotic syndrome.

Journal of medical ultrasonics (2001)
2024

The Role of TNF-α in the Pathogenesis of Idiopathic Nephrotic Syndrome and Its Usefulness as a Marker of the Disease Course.

Journal of clinical medicine
2024

Saliva monitoring of prednisolone in children with first onset steroid-sensitive nephrotic syndrome: Is it possible?

British journal of clinical pharmacology
2024

Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.

Pediatric nephrology (Berlin, Germany)
2024

Characterization of glomerular basement membrane components within pediatric glomerular diseases.

Clinical kidney journal
2024

Mycophenolate Mofetil Versus Prednisone for Induction Therapy in Steroid-Sensitive Idiopathic Nephrotic Syndrome in Children: An Observational Study.

Kidney medicine
2024

Dupilumab for atopic dermatitis in children with idiopathic nephrotic syndrome treated with cyclosporin: a report of two cases.

The Australasian journal of dermatology
2024

Steroid induced ocular complications in idiopathic nephrotic syndrome: a cross sectional single center study.

JPMA. The Journal of the Pakistan Medical Association
2024

Low Birth Weight is Associated with More Severe Course of Steroid-Sensitive Nephrotic Syndrome in Children, Multicentric Study.

Klinische Padiatrie
2024

Lipidomic profiles in serum and urine in children with steroid sensitive nephrotic syndrome.

Clinica chimica acta; international journal of clinical chemistry
2024

Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2024

Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2024

Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation.

iScience
2024

Reconsidering the role of the IL-23/IL-17 immune axis in idiopathic nephrotic syndrome pathogenesis.

Clinical kidney journal
2024

Repeated implants failure in young patient with idiopathic nephrotic syndrome: a case report with brief review of the literature.

BMC oral health
2024

Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2023

Retrospective Cross-Sectional Study Reviewing the Effectiveness of Mycophenolate Mofetil on Saudi Children With Nephrotic Syndrome.

Cureus
2023

Idiopathic Nephrotic Syndrome in Children in Chad: Epidemiology and Clinical Outcomes.

Journal of clinical medicine
2023

Tumor necrosis factor alpha gene polymorphism affects the pattern of idiopathic nephrotic syndrome in Kuwaiti Arab children.

Journal of tropical pediatrics
2024

Ongoing impacts of childhood-onset glomerular diseases during young adulthood.

Pediatric nephrology (Berlin, Germany)
2023

Urinary Apolipoprotein A1 and Neutrophil Gelatinase-associated Lipocalin in Children with Idiopathic Nephrotic Syndrome.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
2023

Burdens and Difficulties Experienced by Parental Caregivers of Children and Adolescents with Idiopathic Nephrotic Syndrome in Mainland China: A Qualitative Study [Letter].

Journal of multidisciplinary healthcare
2023

Burdens and Difficulties Experienced by Parental Caregivers of Children and Adolescents with Idiopathic Nephrotic Syndrome in Mainland China: A Qualitative Study.

Journal of multidisciplinary healthcare
2023

External Validation of a Urinary Biomarker Risk Score for the Prediction of Steroid Responsiveness in Adults With Nephrotic Syndrome.

Kidney international reports
2024

Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).

Clinical and experimental nephrology
2023

Levamisole Modulation of Podocytes' Actin Cytoskeleton in Nephrotic Syndrome.

Biomedicines
2023

The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome.

Nature communications
2023

A Unifying Theory for Idiopathic Nephrotic Syndrome Pathogenesis?

Journal of immunology (Baltimore, Md. : 1950)
2023

Exploring the significance of interleukin-33/ST2 axis in minimal change disease.

Scientific reports
2023

A Study of Dyslipidemia and Its Clinical Implications in Childhood Nephrotic Syndrome.

Cureus
2023

Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences.

Jornal brasileiro de nefrologia
2023

Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis.

Frontiers in immunology
2024

Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome.

Pediatric nephrology (Berlin, Germany)
2023

COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases.

Frontiers in immunology
2023

Complications Related to Childhood Idiopathic Nephrotic Syndrome, Its Treatment and the Associated Risks in Patients.

Cureus
2023

CCL22 and Leptin associated with steroid resistance in childhood idiopathic nephrotic syndrome.

Frontiers in pediatrics
2023

Intussusception as a complication of idiopathic nephrotic syndrome.

Kidney international
2023

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors.

Kidney international reports
2023

Childhood nephrotic syndrome.

Lancet (London, England)
2023

Is kidney biopsy necessary in children with idiopathic nephrotic syndrome?

Acta paediatrica (Oslo, Norway : 1992)
2023

The pattern of steroid sensitivity and steroid resistance in childhood idiopathic nephrotic syndrome: A 5-year retrospective observational descriptive study in a South-East Nigerian tertiary hospital.

Nigerian journal of clinical practice
2023

Delayed diagnosis and exacerbation of hyperlipidemia in idiopathic nephrotic syndrome in children during the COVID-19 pandemic.

Clinical and experimental nephrology
2023

Nutritional Management of Idiopathic Nephrotic Syndrome in Pediatric Age.

Medical sciences (Basel, Switzerland)
2023

Unusual Clinical Presentation of Nephrotic Syndrome With Significant Renal Vein Thrombosis in a Young Male: A Case Report and Literature Review.

Cureus
2023

Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response.

European journal of immunology
2024

The Potential Impact of MYH9 (rs3752462) and ELMO1 (rs741301) Genetic Variants on the Risk of Nephrotic Syndrome Incidence.

Biochemical genetics
2023

Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.

International journal of molecular sciences
2023

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome.

JCI insight
2023

Relationship between H. pylori infection and some other risk factors in the incidence and recurrence of idiopathic nephrotic syndrome in children.

Caspian journal of internal medicine
2023

The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?

Genes
Ver todos os 958 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome nefrótica idiopática.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome nefrótica idiopática

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Mycophenolate mofetil versus prednisone for the initial treatment of idiopathic steroid-sensitive nephrotic syndrome in children in Germany (INTENT): a multicentre, open-label, randomised, controlled, parallel-group, non-inferiority, phase 3 trial.
    The Lancet. Child &amp; adolescent health· 2026· PMID 41856160mais citado
  2. Role of renal doppler in children with idiopathic nephrotic syndrome.
    BMC pediatrics· 2026· PMID 41634692mais citado
  3. Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.
    Science translational medicine· 2026· PMID 41533775mais citado
  4. Factors Influencing Cyclosporine Trough and Two-Hour Post-dose Concentrations in Children with Idiopathic Nephrotic Syndrome.
    Indian pediatrics· 2026· PMID 40920311mais citado
  5. Inferior Vena Cava/Aorta Diameter Index for the Evaluation of Intravascular Volume Status in Children with Idiopathic Nephrotic Syndrome.
    Indian pediatrics· 2026· PMID 40768034mais citado
  6. Humoral Immune Response to SARS-CoV-2 in Children with Idiopathic Nephrotic Syndrome: A Cross-Sectional Exploratory Study.
    Int J Gen Med· 2026· PMID 41971034recente
  7. Navigating the methodological, ethical, and operational challenges of Trials within Cohorts (TwiCs): insights from a French pediatric research-based cohort.
    J Clin Epidemiol· 2026· PMID 41933842recente
  8. Rituximab in a desensitization protocol as a rescue therapy in severe nephrotic syndrome-a case report.
    J Nephrol· 2026· PMID 41921043recente
  9. Angiotensin-converting enzyme insertion/deletion gene polymorphism in children with nephrotic syndrome: Genotype-phenotype correlations.
    Saudi J Kidney Dis Transpl· 2026· PMID 41914989recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:357502(Orphanet)
  2. MONDO:0018170(MONDO)
  3. Sindrome Nefrotica Primaria em Criancas e Adolescentes(PCDT · Ministério da Saúde)
  4. GARD:21539(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55787775(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome nefrótica idiopática
Compêndio · Raras BR

Síndrome nefrótica idiopática

ORPHA:357502 · MONDO:0018170
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Ensaios
12 ativos
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C3496337
Repurposing
9 candidatos
chlorthalidonecarbonic anhydrase inhibitor
dexamethasoneglucocorticoid receptor agonist
dexamethasone-acetatesodium/potassium/chloride transporter inhibitor
+6 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades